In this systematic review and meta-analysis, psychotherapy was the most effective intervention, improving grief disorder ...

Mobile telemedicine was associated with significantly higher chances of initiating hepatitis C virus (HCV) treatment and ...

In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer screens also preserved a favorable harm–benefit ratio ...

In this retrospective cohort study, both low and high early-pregnancy hemoglobin levels were linked to higher rates of severe neonatal morbidity and mortality (SNM-M), stillbirth, and preterm birth ...

In this randomized clinical trial, acupuncture effectively reduces pain and disability in migraine without aura, and baseline whole-brain functional connectivity can predict which patients are most ...

Afshar and colleagues evaluated an artificial intelligence (AI) scribe’s ability to produce clinical documentation and alleviate work exhaustion. 2. Ambient AI use had a significant reduction in work ...

Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study 1. This cohort study found that the IOTA ADNEX ultrasound model ...

Adjunctive fluoxetine significantly reduced vasopressor duration and ICU length of stay in patients with severe sepsis. 2.

Children and adolescents with chronic medical conditions have a significantly higher risk of invasive pneumococcal disease, particularly those who are immunocompromised or have multiple comorbidities.

Intravenous esketamine provides effective adjunctive analgesia after cesarean delivery while also reducing postoperative ...

Oral semaglutide adds a pill-based option for chronic obesity care without changing the core GLP-1 tradeoffs in efficacy and ...

In this randomized controlled trial of adults with central retinal artery occlusion, tenecteplase administration shortly after symptom onset did not significantly improve visual recovery. 2. Those who ...